-
Conduct India-specific Trial: CDSCO Panel Tells Roche on Satralizumab to Treat neuromyelitisoptica spectrum disorders
08 Feb 2024 21:36 GMT
… SEC) functional under the Central Drug Standard Control Organisation (CDSCO) … discontinued the global clinical trial study stating that it was … monoclonal antibody medication that is used for the treatment of … FDC Torsemide plus Eplerenone film coated tablet
-
Synokem gets CDSCO Panel nod to study FDC Torsemide plus Eplerenone film coated tablet
06 Feb 2024 16:08 GMT
… the group of medicines called loop diuretics (water pills). This medicine works by … -system, or RAAS).
Eplerenone is a blood pressure medicine. It is used … by the drug major Synokem Pharmaceutical regarding the Phase III clinical trial of …
-
Is the Price Right? Heart Failure Drug Choices
22 Jan 2024 16:35 GMT
…
That included eplerenone as well as the medicines that are not … .
Do Price Discussions Increase Drug Adherence?
Piña: What did … You're educating the doctors, too, besides educating the … women and minorities in clinical trials. She also enjoys cooking …
-
Conduct BE study with innovator drug as reference product: CDSCO Panel Tells Synokem on FDC Torsemide plus Eplerenone
30 Dec 2023 19:33 GMT
… the group of medicines called loop diuretics (water pills). This medicine works by … of urine.
Eplerenone belongs to the general class of medicines called antihypertensives … proposal presented by the drug major Synokem Pharmaceutical along with the BE …
-
Use of Eplerenone potential strategy to reduce arterial inflammation among persons with HIV: JAMA
22 Dec 2023 04:00 GMT
… HIV.
In the MIRACLE HIV trial, Eplerenone improved myocardial perfusion indices. In … Massachusetts General Hospital and Harvard Medical School, Boston, and colleagues hypothesized … inflammation over 12 months of treatment with eplerenone vs placebo.
The study …
-
Acute Myocardial Infarction Treatment Market to Show Immense Growth at a CAGR of 7.7% During the Study Period (2019-2032), Predicts DelveInsight
01 Dec 2023 00:32 GMT
… include anticoagulation, antiplatelet medication, statin therapy, and other supplementary treatments.
Acute Myocardial Infarction … : Faraday Pharmaceuticals
CSL112: CSL Behring
Olpasiran: Amgen
Learn more about the FDA-approved drugs for …
-
Eplerenone (Inspra) and cost
22 Nov 2023 16:25 GMT
… several factors.
Eplerenone is approved by the Food and Drug Administration (FDA) to … and your doctor will discuss eplerenone in regard to your treatment. The insurance … the active drug in a brand-name medication. A generic drug is considered …
-
Trial to prevent sudden death after a heart attack enrols first patient
21 Nov 2023 09:18 GMT
… 2023: The first clinical trial to challenge the routine … the context of contemporary medical treatment and will provide vital … or less) drug treatment alone is not inferior to drug treatment plus an … et al. Evaluation of eplerenone in the subgroup of EPHESUS …
-
A Predictive Model for Identifying Low Medication Adherence Among Patients with Cirrhosis
01 Nov 2023 08:12 GMT
… Medical Treatment, Social Support, Self-Care Agency and Pill Burden with Medication … spironolactone and eplerenone in management … Simeonova E. Doctors, patients and … Medication Non-Adherence among Patients with Chronic Diseases in Makkah Region. Pharmaceutics …
-
Opinion/decision on a Paediatric investigation plan (PIP): eplerenone,Torasemide, decision type: , therapeutic area: , PIP number: P/0530/2022
24 Oct 2023 12:40 GMT
For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.